Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study

Publication Date

2026

Content Type

article

PubMed ID:

42241337

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS